Allied Biotech Corporation reported earnings results for the half year ended June 30, 2022. For the half year, the company reported sales was TWD 359.77 million compared to TWD 355.99 million a year ago. Net income was TWD 63.09 million compared to TWD 13.69 million a year ago. Basic earnings per share from continuing operations was TWD 0.66 compared to TWD 0.14 a year ago. Diluted earnings per share from continuing operations was TWD 0.66 compared to TWD 0.14 a year ago.